CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease
Wenyi Lu(Tianjin First Center Hospital), Mingfeng Zhao(Nankai University), Hairong Lyu(University of Bristol), Haibo Zhu(Tianjin First Center Hospital), Xin Li(Heilongjiang Vocational Institute of Ecological Engineering), Huan Zhang(First Affiliated Hospital of Chongqing Medical University), Qing Li(Nankai University), Xia Xiao(Hebei Medical University), Xiaoyuan He(Nankai University), Kaiqi Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Rui Sun(Nankai University), Yaqing Cao(Tianjin Medical University), Yanyu Jiang(Nankai University), Yili Jiang(Nankai University), Tao Sui(Tianjin First Center Hospital), Yunxiong Wei(Tianjin First Center Hospital), Ting Yuan(China Pharmaceutical University), Juanxia Meng(Nankai University), Xin Jin(Nankai University)
Cited by 22
Related Papers
The significance of exosomes in the development and treatment of hepatocellular carcinoma
|Molecular Cancer|2020|509
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149
ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice
|Scientific Reports|2015|143
Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
|Cell Death and Disease|2013|129
Synthesis and swelling behaviors of carboxymethyl cellulose-based superabsorbent resin hybridized with graphene oxide
|Carbohydrate Polymers|2016|129